Schonfeld Strategic Advisors LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19,180,034
+86.1%
158,225
+75.9%
0.15%
+68.5%
Q2 2023$10,303,591
+514.6%
89,972
+639.7%
0.09%
+456.2%
Q1 2023$1,676,425
-91.1%
12,163
-91.7%
0.02%
-89.8%
Q4 2022$18,891,598
+142.0%
145,791
+106.5%
0.16%
+141.5%
Q3 2022$7,807,000
+43.5%
70,616
-2.7%
0.06%
+22.6%
Q2 2022$5,441,000
+107.0%
72,602
+115.7%
0.05%
+120.8%
Q1 2022$2,629,000
-28.3%
33,665
-17.3%
0.02%
-27.3%
Q4 2021$3,665,000
+1337.3%
40,700
+1139.7%
0.03%
+1000.0%
Q2 2021$255,000
-65.1%
3,283
-66.5%
0.00%
-66.7%
Q1 2021$731,000
-94.2%
9,801
-86.7%
0.01%
-94.7%
Q4 2020$12,583,000
+1278.2%
73,809
+1035.5%
0.17%
+894.1%
Q3 2020$913,000
+55.8%
6,500
+43.2%
0.02%
+21.4%
Q4 2019$586,000
-92.4%
4,540
-95.6%
0.01%
-93.8%
Q3 2019$7,735,000
-57.5%
102,700
-14.2%
0.23%
-64.7%
Q2 2019$18,188,000
+63.7%
119,700
+74.0%
0.64%
+30.2%
Q3 2018$11,112,000
-13.4%
68,800
-29.1%
0.49%
-29.0%
Q2 2018$12,835,000
+1902.3%
97,100
+1021.0%
0.70%
+1350.0%
Q1 2018$641,000
-87.2%
8,662
-90.4%
0.05%
-88.3%
Q4 2017$5,008,000
-44.7%
90,000
-55.0%
0.41%
-50.4%
Q3 2017$9,063,000
+2453.0%
199,789
+1568.8%
0.83%
+2197.2%
Q1 2017$355,000
+28.2%
11,972
+18.5%
0.04%0.0%
Q4 2016$277,000
-91.7%
10,100
-81.3%
0.04%
-93.6%
Q3 2016$3,319,000
+395.4%
54,038
+53.9%
0.56%
+276.0%
Q2 2016$670,00035,1170.15%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders